Welcome to the Healthcare Policy Pop

Medicare Episodes

Oct. 12, 2023

Coverage with Evidence Development

Kirsten Axelsen, Senior Policy Advisor with global law firm DLA Piper, explains what Coverage with Evidence Development is and how it restricts patients access; the manufacturers of all 10 of the first drugs announced for Me…
June 6, 2023

CMS Alzheimer's Decisions + No Data

Russ Paulsen, Chief Operating Officer for UsAgainstAlzheimer’s, explains how some recent coverage decisions from CMS are affecting thousands of patients a day; ACIP’s public comment period RSV vaccines is officially open; To…